Source credit: U.S. Food and Drug Administration – Lipofit Extreme 2.0 Fat Burner may be harmful due to hidden drug ingredients.
Summary: In a June 4, 2026 safety notice, the FDA advised consumers not to purchase or use Lipofit Extreme 2.0 Fat Burner. FDA lab analysis found fluoxetine in the daytime tablets and 2,4-dinitrophenol (2,4-DNP) in the nighttime tablets, neither of which was listed on the label.
Why it matters for lifters
- Fat-burner risk is still real: This is exactly why aggressive cutting supplements deserve skepticism, especially when products promise rapid results with vague ingredient positioning.
- Hidden ingredients can wreck prep and health fast: Unlisted drug compounds are a problem for general safety, stimulant stacking, and any athlete who cares about what is actually entering their system.
- Shortcut culture remains expensive: If a product markets dramatic physique changes without transparent evidence, this type of FDA alert is the outcome lifters should assume is possible.
What to watch next
- Watch for additional FDA updates, retailer removals, or lab-confirmed ingredient findings tied to this product line.
- Watch your own supplement stack for overlap and avoid buying cutting products from random sites with weak manufacturing transparency.
- If you want body-composition progress, the durable levers are still diet structure, training consistency, sleep, and legitimate evidence-based supplementation.
Health disclaimer: This article is for informational purposes only and is not medical advice. If you used a product named in an FDA warning or develop symptoms after taking a supplement, seek prompt medical guidance.